IE39216L - Pharmaceutical tablets - Google Patents

Pharmaceutical tablets

Info

Publication number
IE39216L
IE39216L IE740803A IE80374A IE39216L IE 39216 L IE39216 L IE 39216L IE 740803 A IE740803 A IE 740803A IE 80374 A IE80374 A IE 80374A IE 39216 L IE39216 L IE 39216L
Authority
IE
Ireland
Prior art keywords
tablets
weight
pharmaceutical tablets
penicillins
pharmaceutical
Prior art date
Application number
IE740803A
Other versions
IE39216B1 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE39216L publication Critical patent/IE39216L/en
Publication of IE39216B1 publication Critical patent/IE39216B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

1422176 Pharmaceutical tablets BEECHAM GROUP Ltd 1 May 1974 [5 May 1973 7 Dec 1973] 21502/73 and 56858/73 Heading A5B Pharmaceutical tablets comprise 10% to 70% by weight of heavy magnesium carbonate, 30% to 85% by weight of a semi-synthetic penicillin or cephalosparin which is suitable for oral administration and 0 to 40% by weight of conventional tabletting ingredients. The tablets may be produced by direct compression in a tablet press. Two different penicillins may be present in the tablets. The penicillins and cephalosparins may be cloxacillin, flucloxacillin, dicloxacillin, an α-ester of carbenicillin or ticarcillin, phenethicillin, propacillin, azidocillin, hetacillin, metampicillin, cyclocillin, epicillin, pivampicillin, talampicillin, cephalexin, cephadrine, ampicillin, amoxycillin and esters and salts thereof. [GB1422176A]
IE803/74A 1973-05-05 1974-04-17 Pharmaceutical tablets IE39216B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2150273A GB1422176A (en) 1973-05-05 1973-05-05 Pharmaceutical tablets
GB5685873 1973-12-07

Publications (2)

Publication Number Publication Date
IE39216L true IE39216L (en) 1974-11-05
IE39216B1 IE39216B1 (en) 1978-08-30

Family

ID=26255363

Family Applications (1)

Application Number Title Priority Date Filing Date
IE803/74A IE39216B1 (en) 1973-05-05 1974-04-17 Pharmaceutical tablets

Country Status (10)

Country Link
JP (1) JPS5714649B2 (en)
CA (1) CA1018890A (en)
DE (1) DE2421273A1 (en)
DK (1) DK145712C (en)
FR (1) FR2227856B1 (en)
GB (1) GB1422176A (en)
IE (1) IE39216B1 (en)
IL (1) IL44646A (en)
NL (1) NL7406023A (en)
SE (1) SE402405B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (en) * 1978-12-22 1980-07-10 Donald E Panoz NEW GALENIC PREPARATION FOR THE ORAL ADMINISTRATION OF MEDICINES WITH PROGRAMMED ASSOCIATION, AND METHOD FOR THE PRODUCTION THEREOF
DE3239592C2 (en) * 1982-10-26 1986-10-30 Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga Antibacterial drug
ES2019583B3 (en) * 1985-10-19 1991-07-01 Beecham Group Plc COMPOSITION FOR THE TREATMENT OF INFECTIONS.
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IS7724A (en) * 2005-03-02 2006-09-03 Actavis Group Composition of tablets with rapid decomposition containing heavy magnesium carbonate
EP1728511A1 (en) * 2005-05-31 2006-12-06 Faust Pharmaceuticals New use of phenethicillin and salts thereof.
CA2788740C (en) * 2010-02-03 2017-09-12 Merck Patent Gmbh Directly compressible magnesium hydroxide carbonate
WO2012124827A1 (en) * 2011-03-17 2012-09-20 協和化学工業株式会社 Binder for tablet forming

Also Published As

Publication number Publication date
AU6853574A (en) 1975-11-06
GB1422176A (en) 1976-01-21
IL44646A0 (en) 1974-06-30
DK145712B (en) 1983-02-07
SE402405B (en) 1978-07-03
CA1018890A (en) 1977-10-11
FR2227856A1 (en) 1974-11-29
JPS5029732A (en) 1975-03-25
DK145712C (en) 1983-07-25
IL44646A (en) 1977-04-29
JPS5714649B2 (en) 1982-03-25
FR2227856B1 (en) 1978-02-03
NL7406023A (en) 1974-11-07
IE39216B1 (en) 1978-08-30
DE2421273A1 (en) 1974-11-14

Similar Documents

Publication Publication Date Title
IE39216B1 (en) Pharmaceutical tablets
GB1508977A (en) Beta-lactam antibiotic from streptomyces clavuligerus
IE812232L (en) Composition
ES430431A1 (en) Direct compression tabletting composition and pharmaceutical tablets produced therefrom
IE37757B1 (en) Penicillins and cephalosporins
EP0318377A3 (en) Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications
ES408226A1 (en) 1-(Quinazolinyl) indol-3-ylacetic acids, esters and amides
GB1380171A (en) Medicinal tablets
EP0312813A3 (en) Preparation of clavulanic acid and its salts and esters
GB1426484A (en) Cis-20-deethy-eburnamonine
IE39741L (en) Phenyl-benzoic acid pharmaceuticals
ES8301107A1 (en) An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant.
GB1508978A (en) Esters of clavulanic acid
GB1439240A (en) Chewable aspirin tablet
GB1371939A (en) Pyridine carboxamides
GB1504426A (en) Clavulanic acid derivatives
GB1417539A (en) Pyrazolo-qzinoline derivative and compositions thereof
AU7071387A (en) A pharmaceutical formulation containing indomethacin
IL42201A (en) 2-((1-benzylcyclopentyl)-imino)pyrrolidine
CA1012159A (en) Dialkylaminoalkyl esters of 2-(6-methoxy-2-naphthyl) propionic acid and the pharmaceutically acceptable salts thereof
GB1368251A (en) Theophylinylmethylethanoic acid ester
GB1275164A (en) New heterocyclic carboxylic acids, process for their production and pharmaceutical preparations having a content thereof
IT1166614B (en) 2-Methoxy-phenoxy:acetate of talampicillin - prepd. by hydrolysis of metampicillin phthalidyl ester in two-phase solvent and treatment of aq. phase with 2-methoxy-phenoxyacetic acid sal
AU461353B2 (en) A PROCESS FOR THE PREPARATION OF NEW d-AMINOPENICILLINS AND SUCH PENICILLINS, AND INTERMEDIATES AND PHARMACEUTICAL PREPARATIONS
IE782539L (en) Penicillin derivatives